Our UHN programs and services are among the most advanced in the world. We have grouped our physicians, staff, services and resources into 10 medical programs to meet the needs of our patients and help us make the most of our resources.
University Health Network is a health care and medical research organization in Toronto, Ontario, Canada. The scope of research and complexity of cases at UHN has made us a national and international source for discovery, education and patient care.
Our 10 medical programs are spread across eight hospital sites – Princess Margaret, Toronto General, Toronto Rehab’s five sites, Toronto Western – as well as our education programs through the Michener Institute of Education at UHN. Learn more about the services, programs and amenities offered at each location.
Maps & Directions
Find out how to get to and around our nine locations — floor plans, parking, public transit, accessibility services, and shuttle information.
Ways You Can Help
Being touched by illness affects us in different ways. Many people want to give back to the community and help others. At UHN, we welcome your contribution and offer different ways you can help so you can find one that suits you.
The Newsroom is the source for media looking for information about UHN or trying to connect with one of our experts for an interview. It’s also the place to find UHN media policies and catch up on our news stories, videos, media releases, podcasts and more.
Stem cell technology offers the promise of recreating, treating, and replacing diseased organs in the human body. With our research, we plan to use regenerative medicine to tackle critical diseases such as diabetes, heart failure, and liver failure.
DiabetesTo generate beta cells that can store and release insulin, we will grow stem cells in vitro using specific culture conditions. We artificially create a favourable environment for the cells to develop along the pancreatic lineage and in the end transform into the beta-like cells. In essence, we take the cells from a pluripotent state (where they can become any type of cell) to a unipotent, committed cell type, ideally a beta cell. To evaluate the efficiency of our process, we use flow cytometry, fluorescence imaging and gene expression analysis to phenotypically (by means of physical and biochemical characteristics) and molecularly characterize our final product. Additionally, we perform functional analysis both in vitro and in vivo.
Heart FailureWe use “genetic knockout” in experimental models, where we manipulate and change the expressed genes. We have applied this technique quite successfully and understood that by removing specific molecules, we can affect the heart in a certain way. We can induce the heart to regenerate itself by using these exact techniques. We use ultrasound (echocardiography) as a way to mark our progress and observe the overall physiological change in the heart. We also apply molecular biology to better understand each of the individual changes and how they are affected by our manipulations.
Liver DiseaseWe use our unique access to human liver tissue to carefully describe what a human liver actually “is”. Once described, we use technologies similar to those described above to drive multi-potential stem cells towards mature liver cells. We are developing ways of combining these cells to create artificial, outside-the-body liver units. We are also testing whether the cells, alone or in combination, can themselves be used to treat liver disease. In all of these studies, cutting-edge technologies, such as single cell RNA sequencing, are being employed.
Regenerative MedicineDr. Filio BilliaEmail:
Cell TherapyMaria Cristina NostroEmail:
Liver DiseaseDr. Nazia SelznerEmail: